Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Losaar 100 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Losaar 100

Approved

STANDARD

Losaar 100

Hebei Tiancheng Pharmaceutical Co., Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: a89b845956c3c51b
Company: Hebei Tiancheng Pharmaceutical Co., Ltd.
Type: Standard

Approval Details

Approval Id: a89b845956c3c51b
Drug Approval Philippines Name: Losaar 100
Product Name: Losaar 100
Registration Number: DRP-8523
Brand Name: Losaar 100
Generic Name: Losartan Potassium
Dosage Form: Film Coated Tablet
Dosage Strength: 100 mg
Manufacturer: Hebei Tiancheng Pharmaceutical Co., Ltd.
Importer: AMB HK Enterprises Inc.
Distributor: AMB HK Enterprises Inc.
Issuance Date: 27 September 2024
Expiry Date: 25 October 2029
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

a89b845956c3c51b

Type

Standard

Back to Philippines FDA Approvals